Contents on this page
APONTIS PHARMA AG
SHARE PRICE
Here you will find the latest information about the APONTIS PHARMA share as well as current share price data.
APONTIS PHARMA AG
ANALYSTS
Latest update Institution Analyst Recommendation Price target (EUR) Download
09/03/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 35,00 (41,00)
12/03/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30,00 (32,00)
07/04/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 33,00 (35,00)
19/04/2022 Montega Research Henrik Markmann BUY (BUY) 26,00 Download
11/05/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31,00 (33,00)
11/05/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30,00 (30,00)
11/05/2022 Montega Research Henrik Markmann BUY (BUY) 26,00 (26,00) Download
30/05/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30,00 (30,00) Download
28/06/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31,00 (31,00) Download
11/08/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 31,00 (31,00) Download
12/08/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 29,00 (31,00) Download
12/08/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30,00 (30,00) Download
16/08/2022 Montega Research Tim Kruse BUY (BUY) 26,00 (26,00) Download
24/10/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 27,00 (29,00) Download
08/11/2022 Montega Research Tim Kruse, CFA BUY (BUY) 26,00 (26,00) Download
10/11/2022 Warburg Research Dr. Christian Ehmann BUY (BUY) 27,00 (27,00) Download
11/11/2022 Hauck & Aufhäuser Alexander Galitsa BUY (BUY) 30,00 (30,00) Download
11/11/2022 Montega Research Tim Kruse, CFA BUY (BUY) 26,00 (26,00) Download (Only German)
SHARE INFORMATION
COMPANY FUNDAMENTALS
First day of trading 11 May 2021
Issue price EUR 19.00
Ticker symbol APPH
ISIN (InternationalSecurities Identification Number) DE000A3CMGM5
WKN (German Securities Code) A3CMGM
LEI (Legal Entity Identifier) 894500ETO1J6MR8PDF91
Stock Exchange and trading venue Frankfurt Stock Exchange/Xetra
Trading Segment Scale (Open Market)
Total Number Of Shares 8,500,000
Share Capital EUR 8,500,000.00
Type of share Ordinary bearer shares without nominal value (no-par shares)
Designated Sponsor Hauck & Aufhäuser Privatbankiers AG
Specialist Bankhaus Scheich Wertpapierspezialist AG
Paying Agent Bankhaus Gebr. Martin AG
Company Profile
Initial Public Offering
Due to applicable legal restrictions, access to this section of our website is restricted to users located in certain jurisdictions. Please confirm your location here

Please select your country

Please enter City

Please enter ZIP code

Contact 
Investor Relations
Do not miss any publications or news about APONTIS PHARMA AG. By registering for our IR mailings, you will always stay informed.
Subscribe Contact
Sven